HB 500-1989
32019R0500
32018D0500
32017D0500
32015R0500
32013D0500
32006D0500
32012D0500
32009R0500
32013R0500
Commission Regulation (EU) No 500/2013 of 30 May 2013 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, Adoxophyes orana granulovirus strain BV-0001, azoxystrobin, clothianidin, fenpyrazamine, heptamaloxyloglucan, metrafenone, Paecilomyces lilacinus strain 251, propiconazole, quizalofop-P, spiromesifen, tebuconazole, thiamethoxam and zucc
32007D0500
32000D0500
31998D0500
31994R0500
31991D0500
31992D0500
31994D0500
94/500/EC: Council Decision of 21 February 1994 concerning the conclusion of an Agreement in the form of an Exchange of Letters between the European Community and the Republic of Poland amending Annex IVb to the Interim Agreement between the European Coal and Steel Community and the European Economic Community, of the one part, and the Republic of Poland, of the other part, and to the Europe Agreement between the European Communities and their Me
31990D0500
EIA 500
Recommended Practice for Measurement of X-Radiation from Projection Cathode-Ray Tubes
\u041f\u041d\u0421\u0422 500-2020
Nanotechnologies. Part 13. Graphene and two dimensional (2D) materials based on it. Terms and definitions